Profile of:
Nurullah Akkoc
I graduated from the Medical Faculty of Ege University in Izmir, Turkey in 1982. I obtained postgraduate training in the USA and Germany. I served as the Chief of the Division of Rheumatology and Immunology between 1998 and 2017 at Dokuz Eylul University in Izmir. Currently I am working as the chief of the Division of Rheumatology at the Department of Medicine of the Celal Bayar University in Manisa, a town near Izmir. I served as the President of Turkish Society for Rheumatology (2012-2014), and as the Vice President (2014-2015) and the President of Turkish Rheumatology Federation (2015-2016). My primary research interest is clinical and genetic aspects of ankylosing spondylitis and related spondyloarthritis, rheumatoid arthritis, and Takayasu’s arteritis. I have also published more than 300 scientific articles, letters, and abstracts. I have been a member of the Assessment in Ankylosing Spondylitis International Society (ASAS) since 1996. I am also a member of the scientific committee of the The EuroSpA Collaboration Network. I serve as a co-section editor for SpA Current Rheumatology Reports.
Full name: Nurullah Akkoc
Current country: Turkey
Membership level: Full
Type of membership: Member
Number of publications: 23
Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results (2024)
https://www.ncbi.nlm.nih.gov/pubmed/38933720
Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study (2024)
https://www.ncbi.nlm.nih.gov/pubmed/38902436
Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry (2024)
https://www.ncbi.nlm.nih.gov/pubmed/37348053
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons (2023)
https://www.ncbi.nlm.nih.gov/pubmed/36633815
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration (2022)
https://www.ncbi.nlm.nih.gov/pubmed/35985172
A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry (2022)
https://www.ncbi.nlm.nih.gov/pubmed/35546332
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis (2022)
https://www.ncbi.nlm.nih.gov/pubmed/35323903
European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response (2022)
https://www.ncbi.nlm.nih.gov/pubmed/34940840
Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis. (2021)
https://pubmed.ncbi.nlm.nih.gov/34161253/
European bio-naïve spondyloarthritis patients initiating TNFi: Time trends in baseline characteristics, treatment retention and response (2021)
https://pubmed.ncbi.nlm.nih.gov/34940840/
Do mobility exercises in different environments have different effects in ankylosing spondylitis? (2021)
https://pubmed.ncbi.nlm.nih.gov/34962245/
JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold? (2021)
https://pubmed.ncbi.nlm.nih.gov/33909185/
Assessing rheumatologists’ attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort (2021)
https://pubmed.ncbi.nlm.nih.gov/32797363/
Is Axial Spondyloarthritis More Common Than Rheumatoid Arthritis? (2020)
https://pubmed.ncbi.nlm.nih.gov/32712723/
The adaptation of the Turkish version of the Assessment of Knowledge in Ankylosing Spondylitis Patients by a Self-Administered Questionnaire (2020)
https://pubmed.ncbi.nlm.nih.gov/33089086/
Prevalence of Spondyloarthritis Among Patients Who Underwent Lumbar Disc Herniation Surgery (2020)
https://pubmed.ncbi.nlm.nih.gov/32851367/
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/
Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30946743/
Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29858176/
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative (2018)
https://pubmed.ncbi.nlm.nih.gov/29310963/
An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS (2018)
https://pubmed.ncbi.nlm.nih.gov/29038299/
Do major histocompatibility complex tag single nucleotide polymorphisms accurately identify HLA-B27 in the Turkish population? (2017)
https://pubmed.ncbi.nlm.nih.gov/28386763/
Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies (2017)
https://pubmed.ncbi.nlm.nih.gov/28197884/
